Type I Atherosclerotic Lesion C4703474
The earliest visible sign of fatty deposits forming in artery walls, a normal part of aging that does not cause symptoms.
Key facts at a glance
- ICD-10
- I78.0
- ICD-11
- BA00.0
- Body system
- cardiovascular
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Chest discomfort
Syncope
Chest discomfort or palpitations
(cardiovascular)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Shortness of breath
(cardiovascular)Fatigue
(cardiovascular)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Cardiovascular Exercise Program
Structured aerobic exercise regimen including activities like walking, cycling, or swimming to improve circulation, reduce inflammation, and support healthy lipid metabolism.
Disease management and monitoring
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Heart-Healthy Mediterranean Diet
Anti-inflammatory dietary pattern emphasizing fruits, vegetables, whole grains, lean proteins, and healthy fats. This approach supports healthy cholesterol levels and vascular function.
Additional treatment options
Smoking Cessation
Comprehensive smoking cessation program addressing nicotine addiction through behavioral support, counseling, and evidence-based strategies to eliminate tobacco use.
lifestyleCardiovascular Risk Factor Monitoring
Regular assessment of lipid panels, blood pressure, blood glucose, and vascular imaging to track progression or improvement of atherosclerotic changes.
monitoringOmega-3 Fatty Acid Supplementation
Incorporation of EPA and DHA omega-3 fatty acids through diet or supplements to support anti-inflammatory processes and cardiovascular health.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Type I Atherosclerotic Lesion C4703474?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Virmani R, Burke AP, Kolodgie FD. Morphology of atherosclerotic lesions in the coronary arteries. Cardiovasc Pathol. 2003;12(5):271-280.
Libby P, Buring JE, Badimon L. 2019 ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2020;41(1):111-188.
Stary HC, Chandler AB, Glagov S. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. Circulation. 1994;89(5):2462-2478.
Bentzon JF, Otsuka F, Virmani R. Mechanisms of plaque formation and rupture. Circ Res. 2014;114(12):1852-1866.
Medication Comparisons
Compare medications used to treat Type I Atherosclerotic Lesion C4703474. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy